Left ventricular hypertrophy in athletes and hypertensive patients

Journal of Clinical Hypertension

Volumn 19, Issue 4, 2017, Pages 413-417

  Lovic, Dragan ^a   Narayan, Puneet ^a   Pittaras, Andreas ^a   Faselis, Charles ^a   Doumas, Michael ^a   Kokkinos, Peter ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Keywordsexercise hypertension, hypertension arrhythmias, left ventricular hypertrophy, otherDOI: 10.1111 jch.12977

Indexed keywords

ATHLETE; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE; FOLLOW UP; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HUMAN; HYPERTENSION; PHYSICAL ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SUDDEN CARDIAC DEATH; SYSTOLIC DYSFUNCTION; WALL STRESS; COMPLICATION; HYPERTROPHY, LEFT VENTRICULAR; PATHOPHYSIOLOGY; PHYSIOLOGY;

ATHLETES; EXERCISE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR;

EID: 85014057164     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12977     Document Type: Review

References (38)

1. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39.
2. Levy D, Savage D, Garrison R, Anderson K, Kannel W, Castelli W. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987;59:956–960.
3. Beverly L, Blase C. Left ventricular hypertrophy pathogenesis, detection, and prognosis. Circulation. 2000;102:470–479.
4. Frohlich ED, Apstein C, Chobanian AV, et al. The heart in hypertension. N Engl J Med. 1992;327:998–1008.
5. Longhurst JC, Kelly AR, Gonyea WJ, et al. Echocardiographic left ventricular masses in distance runners and weight lifters. J Appl Physiol. 1980;48:154–162.
6. Morganroth J, Maron BJ, Henry WL, et al. Comparative left ventricular dimensions in trained athletes. Ann Intern Med. 1975;82:521–524.
7. Lattanzi F, Di Bello V, Picano E, et al. Normal ultrasonic myocardial reflectivity in athletes with increase left ventricular mass. Circulation. 1992;85:1828–1834.
8. Drazner M. The progression of hypertensive heart disease. Circulation. 2011;123:327–334.
9. Gosse P, Cremer A, Vircoulon M, et al. Prognostic value of the extent of left ventricular hypertrophy and its evolution in the hypertensive patient. J Hypertens. 2012;30:2403–2409.
10. Lovic D, Erdine S, Catakoğlu AB. How to estimate left ventricular hypertrophy in hypertensive patients. Anadolu Kardiyol Derg. 2014;14:389–95.
11. Garg S, de Lemos JA, Ayers C, et al. Association of a 4-tiered classification of LV hypertrophy with adverse CV outcomes in the general population. J Am Coll Cardiol Img. 2015;8:1034–1041.
12. Lovic D, Manolis A, Lovic B, Stojanov V, Pittaras A, Jakovljevic B. The pathophysiological basis of carotid baroreceptor stimulation for the treatment of resistant hypertension. Curr Vasc Pharmacol. 2014;12:16–22.
13. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948–1955.
14. Marwick T, Gillebert T, Aurigemma G, et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr. 2015;28:727–54.
15. Giuseppe M, Robert F, Krzysztof N, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society. Eur Heart J. 2013;34:2159–219.
16. Henchen S. Skilanglauf und skiwettaluf. Einemedizinischesportstudie. Meit Med Klin. 1898;2:15.
17. Deutsch F, Kauf E. Heart and Athletics. St. Louis, MO: CV Mosby Company; 1927.
18. Clifford PS, Hanel B, Secher NH. Arterial blood pressure response to rowing. Med Sci Sport Exerc. 1994;26:715–719.
19. Rost R. The athlete's heart: historical perspective. In: Maron BJ, ed. Cardiology Clinics, the Athlete's Heart. Philadelphia, PA: WB Saunders Co; 1992:197–207.
20. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991;324:295–301.
21. Barry J, Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation. 2006;114:1633–1644.
22. Martin WH III, Coyle EF, Bloomfield SA, Ehsani AA. Effects of physical deconditioning after intense endurance training on left ventricular dimensions and stroke volume. J Am Coll Cardiol. 1986;7:982–989.
23. Frohlich ED, Apstein C, Chobanian AV, et al. The progression of hypertensive heart disease. Circulation. 2011;123:327–334.
24. American College of Sports Medicine, Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, et al. Exercise and physical activity for older adults. Med Sci Sports Exerc. 2009;41:1510–30.
25. Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116:1094–105.
26. Kokkinos P, Myers J. Exercise and physical activity: clinical outcomes and applications. Circulation. 2010;122:1637–48.
27. Kokkinos PF, Narayan P, Colleran J, et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med. 1995;333:1462–1467.
28. Lewis JF, Spirito P, Pelliccia A, et al. Doppler echocardiographic assessment of diastolic filling in distinguishing “athletes heart” from hypertrophic cardiomyopathy. Br Heart J. 1992;68:296–300.
29. Rials SJ, Wu Y, Ford N, et al. Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart. Circulation. 1995;91:426–430.
30. Kokkinos PF, Narayan P, Fletcher RD, Tsagadopoulos D, Papademetriou V. Effects of aerobic training on exaggerated blood pressure response to exercise in African-Americans with severe systemic hypertension treated with indapamide +/- verapamil +/- enalapril. Am J Cardiol. 1997;79:1424–1426.
31. Kokkinos P, Pittaras A, Narayan P, Faselis C, Singh S, Manolis A. Exercise capacity and blood pressure associations with left ventricular mass in prehypertensive individuals. Hypertension. 2007;49:55–61.
32. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J. 2001;141:334–41.
33. Bombelli M, Facchetti R, Carugo S, et al. Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values. J Hypertens. 2009;27:2458–2464.
34. Katholi RE, Couri DM. Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens. 2011;2011:495349.
35. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.
36. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014;129:e28–e292.
37. Kokkinos P, Pittaras A, Manolis A, et al. Exercise capacity and 24-h blood pressure in prehypertensive men and women. Am J Hypertens. 2006;19:251–258.
38. Spirito P, Pelliccia A, Proschan MA, et al. Morphology of the “athlete's heart” assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol. 1994;74:802–806.